Abstract
Purpose
Malignancies of the upper gastrointestinal tract are rare in early-onset patients outside the hereditary genetic disorders. There are few reports describing adenocarcinoma of the esophagogastric junction (AEG) in extremely early-onset patients aged under 50 years old. The aim of this study was to describe the clinicopathological features and prognosis of adenocarcinoma of esophagogastric junction (AEG) in early-onset patients among three successive periods: 1975–1989 (period 1), 1990–2004 (period 2), and 2005–2017 (period 3).
Methods
Between 1975 and 2017, data were extracted from the Surveillance, Epidemiology, and End Results database, and 18,278 patients with AEG were enrolled. Three age groups of patients were identified: < 50, 50–69, and ≥ 70 years of age. Clinicopathological characteristics and prognostic outcomes were reviewed and compared among three groups over three periods (1975–89, 1990–04, and 2005–2017). Multivariate Cox regression analysis was performed to adjust for covariate effects related to both overall survival (OS) and cancer-specific survival (CSS).
Results
Among three age groups, early-onset patients were more likely to present with higher tumor grade, advanced nodal, and distant metastatic disease at diagnosis than other groups (p < 0.01 for both). In comparison to the older group, a higher proportion of patients in the early-onset group received chemotherapy and radiation treatment. After adjusting for covariates, early-onset patients had a better CSS and OS than elderly patients.
Conclusions
Early-onset AEG patients were more likely than other age groups to present with advanced disease upon diagnosis. However, the prognosis of early-onset patients was better than their older counterparts after adjustment for covariates. The dissimilarities in tolerance to treatment among early-onset, middle-aged, and elderly patients could be the reason for this difference.
Similar content being viewed by others
Availability of data and materials
The datasets generated and analyzed during the current study are publicly available.
References
Al-Refaie WB, Hu C-Y, Pisters PWT et al (2011) Gastric adenocarcinoma in young patients: a population-based appraisal. Ann Surg Oncol 18(10):2800–2807
Anderson WF, Rabkin CS, Turner N et al (2018) The changing face of noncardia gastric cancer incidence among US non-hispanic whites. J Natl Cancer Inst 110(6):608–615
Arnold M, Park JY, Camargo MC et al (2020) Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut 69(5):823–829
Camargo MC, Anderson WF, King JB et al (2011) Divergent trends for gastric cancer incidence by anatomical subsite in US adults. Gut 60(12):1644–1649
Codipilly DC, Sawas T, Dhaliwal L et al (2021) Epidemiology and outcomes of young-onset esophageal adenocarcinoma: an analysis from a population-based database. Cancer Epidemiol Biomarkers Prevent 30(1):142–149
Donders ART, van der Heijden GJMG, Stijnen T et al (2006) Review: a gentle introduction to imputation of missing values. J Clin Epidemiol 59(10):1087–1091
Donohoe CL, MacGillycuddy E, Reynolds JV (2011) The impact of young age on outcomes in esophageal and junctional cancer. Dis Esophagus 24(8):560–568
Heer EV, Harper AS, Sung H et al (2020) Emerging cancer incidence trends in Canada: the growing burden of young adult cancers. Cancer 126(20):4553–4562
Isobe Y, Nashimoto A, Akazawa K et al (2011) Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer 14(4):301–316
Joshi S, Badgwell B (2021) Current treatment and recent progress in gastric cancer. Cancer J Clin 71(3):264–279
Kong X, Wang J-L, Chen H-M et al (2012) Comparison of the clinicopathological characteristics of young and Elderly patients with gastric carcinoma: a meta analysis. J Surg Oncol 106(3):346–352
Liu X-Y, Liang H, Deng J-Y et al (2010) Analysis of clinicopathological characteristics and prognosis of patients with gastric cancer in different locations after radical resection. Zhonghua Wei Chang Wai Ke Za Zhi = Chin J Gastrointest Surg 13(3):181–184
Llanos O, Butte JM, Crovari F et al (2006) Survival of young patients after gastrectomy for gastric cancer. World J Surg 30(1):17–20
Nakamura R, Saikawa Y, Takahashi T et al (2011) Retrospective analysis of prognostic outcome of gastric cancer in young patients. Int J Clin Oncol 16(4):328–334
Park HJ, Ahn JY, Jung H-Y et al (2014) Clinical characteristics and outcomes for gastric cancer patients aged 18–30 years. Gastric Cancer 17(4):649–660
Pisanu A, Podda M, Cois A et al (2014) Gastric cancer in the young: Is it a different clinical entity? A retrospective cohort study. Gastroenterol Res Pract. https://doi.org/10.1155/2014/125038
Saito H, Takaya S, Fukumoto Y et al (2012) Clinicopathologic characteristics and prognosis of gastric cancer in young patients. Yonago Acta Med 55(3):57–61
Santoro R, Carboni F, Lepiane P et al (2007) Clinicopathological features and prognosis of gastric cancer in young European adults. Br J Surg 94(6):737–742
Sawas T, Manrique GC, Iyer PG et al (2019) Young adults with esophageal adenocarcinoma present with more advanced stage tumors and have shorter survival times. Clin Gastroenterol Hepatol 17(9):1756–1762
Siewert JR, Feith M, Stein HJ (2005) Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol 90(3):139–146
Smith BR, Stabile BE (2009) Extreme aggressiveness and lethality of gastric adenocarcinoma in the very young. Arch Surg 144(6):506–510
Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249
Takatsu Y, Hiki N, Nunobe S et al (2016) Clinicopathological features of gastric cancer in young patients. Gastric Cancer 19(2):472–478
Theuer CP, de Virgilio C, Keese G et al (1996) Gastric adenocarcinoma in patients 40 years of age or younger. Am J Surg 172(5):473–477
Wang W, Xue Y, Zhuo C et al (2015) Analysis of clinicopathological features and prognosis in patients with advanced gastric cancer in different locations. Zhonghua Wei Chang Wai Ke Za Zhi = Chin J Gastrointest Surg 18(12):1248–1252
Xu J, Cao J, Wang L et al (2017) Prognostic performance of three lymph node staging schemes for patients with Siewert type II adenocarcinoma of esophagogastric junction. Sci Rep 7(1):10123
Yoon HY, Kim CB (2011) Gastroesophageal junction adenocarcinoma of young patients who underwent curative surgery: a comparative analysis with older group. Surg Today 41(2):203–209
Zhou Z, Zhang H, Xu Z et al (2015) Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction. World J Surg Oncol 13:197
Zhu Z, Wang Y, Li F et al (2019) Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum. Zhonghua Wei Chang Wai Ke Za Zhi = Chin J Gastrointest Surg 22(2):149–155
Funding
This study was funded by Guangdong Medical Scientific Research Foundation, (B2022168); Natural Science Foundation of Guangdong Provincial of China (2020A1515010573); National key Clinical Specialty Construction Project (2021–2024, No. 2022YW030009).
Author information
Authors and Affiliations
Contributions
All authors have helped in performing this research; Conception and design: HL, JZ, GZ, YL. Collection and assembly of data: HL, JZ, GZ. Data analysis and interpretation: HL, JZ. Manuscript writing: all authors. Final approval of the manuscript: all authors.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval and consent to participate
The SEER data did not require institutional ethical support or informed consent to access its free public database.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lai, H., Zheng, J., Zhou, G. et al. Clinical characteristics and prognostic outcomes for adenocarcinoma of esophagogastric junction in early-onset patients: a population-based appraisal. J Cancer Res Clin Oncol 149, 14941–14952 (2023). https://doi.org/10.1007/s00432-023-05210-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-023-05210-2